Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Bicycle Therapeutics Plc ADR (NASDAQ: BCYC) was $14.89 for the day, up 3.69% from the previous closing price of $14.36. In other words, the price has increased by $3.69 from its previous closing price. On the day, 0.68 million shares were traded. BCYC stock price reached its highest trading level at $15.19 during the session, while it also had its lowest trading level at $14.45.
Ratios:
Our analysis of BCYC’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 17.13 and its Current Ratio is at 17.13. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on November 08, 2024, initiated with a Equal-Weight rating and assigned the stock a target price of $25.
On September 06, 2024, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $35.
B. Riley Securities Downgraded its Buy to Neutral on August 07, 2024, whereas the target price for the stock was revised from $33 to $28.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 02 ’25 when Thompson Travis Alvin bought 2,016 shares for $14.00 per share.
Young Alethia bought 1,395 shares of BCYC for $19,530 on Jan 02 ’25. On Jan 02 ’25, another insider, Arroyo Santiago, who serves as the Officer of the company, bought 4,943 shares for $14.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCYC now has a Market Capitalization of 1028094976 and an Enterprise Value of 148320256. For the stock, the TTM Price-to-Sale (P/S) ratio is 27.80 while its Price-to-Book (P/B) ratio in mrq is 1.24. Its current Enterprise Value per Revenue stands at 4.02 whereas that against EBITDA is -0.783.
Stock Price History:
Over the past 52 weeks, BCYC has reached a high of $28.67, while it has fallen to a 52-week low of $12.17. The 50-Day Moving Average of the stock is -25.50%, while the 200-Day Moving Average is calculated to be -33.48%.
Shares Statistics:
BCYC traded an average of 605.16K shares per day over the past three months and 470150 shares per day over the past ten days. A total of 69.02M shares are outstanding, with a floating share count of 65.57M. Insiders hold about 4.99% of the company’s shares, while institutions hold 62.73% stake in the company. Shares short for BCYC as of 1734048000 were 3433674 with a Short Ratio of 5.67, compared to 1731628800 on 3524722. Therefore, it implies a Short% of Shares Outstanding of 3433674 and a Short% of Float of 7.79.
